Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADRCs for hand dysfunction in systemic sclerosis
NCT07360808Recruiting
- Sponsor
- Plus Therapeutics
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial of Cytori Cell Therapy in systemic sclerosis (SSc), sponsored by Plus Therapeutics. Primary endpoint: Cochin Hand Function Scale at 24 weeks. Started Dec 2025; status: recruiting.
02
Drugs
Cytori Cell Therapy
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT07360808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07360808.